Loomis, Sayles & Company
MEDP icon

Loomis, Sayles & Company’s Medpace MEDP Stock Holding History

Loomis, Sayles & Company’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Sell
2,971
-54
-2% -$24.9K ﹤0.01% 499
2026
Q1 		$1.45M Buy
+3,025
New +$1.55M ﹤0.01% 481
2024
Q4 		– Sell
-205,798
Closed -$68.7M – 763
2024
Q3 		$68.7M Buy
205,798
+13,880
+7% +$5.27M 0.09% 92
2024
Q2 		$79M Buy
191,918
+33,144
+21% +$13.1M 0.11% 74
2024
Q1 		$64.2M Sell
158,774
-5,100
-3% -$1.79M 0.09% 94
2023
Q4 		$50.2M Buy
163,874
+1,345
+0.8% +$363K 0.08% 118
2023
Q3 		$39.4M Sell
162,529
-5,072
-3% -$1.3M 0.07% 142
2023
Q2 		$40.3M Sell
167,601
-1,542
-0.9% -$320K 0.06% 141
2023
Q1 		$31.8M Buy
169,143
+1,995
+1% +$413K 0.06% 170
2022
Q4 		$35.5M Sell
167,148
-72,528
-30% -$14.5M 0.07% 146
2022
Q3 		$37.7M Sell
239,676
-2,873
-1% -$458K 0.08% 131
2022
Q2 		$36.3M Sell
242,549
-16,593
-6% -$2.4M 0.07% 144
2022
Q1 		$42.4M Buy
259,142
+25,900
+11% +$4.27M 0.06% 158
2021
Q4 		$50.8M Buy
233,242
+139,767
+150% +$29.3M 0.06% 146
2021
Q3 		$17.7M Buy
+93,475
New +$17M 0.02% 317
2019
Q2 		– Sell
-481
Closed -$28K – 676
2019
Q1 		$28K Buy
481
+183
+61% +$10.9K ﹤0.01% 571
2018
Q4 		$16K Sell
298
-287
-49% -$15.8K ﹤0.01% 740
2018
Q3 		$35K Sell
585
-24
-4% -$1.31K ﹤0.01% 634
2018
Q2 		$26K Sell
609
-140
-19% -$5.66K ﹤0.01% 732
2018
Q1 		$26K Hold
749
– – ﹤0.01% 746
2017
Q4 		$27K Hold
749
– – ﹤0.01% 732
2017
Q3 		$24K Buy
749
+356
+91% +$10.9K ﹤0.01% 739
2017
Q2 		$11K Buy
393
+46
+13% +$1.29K ﹤0.01% 795
2017
Q1 		$10K Hold
347
– – ﹤0.01% 808
2016
Q4 		$13K Buy
+347
New +$11.6K ﹤0.01% 822

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Loomis, Sayles & Company's MEDP Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Medpace (MEDP) stake by 1.8% in Q2 2026, selling an estimated $24.9K and leaving 2,971 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Loomis, Sayles & Company first reported a position in MEDP in Q4 2016 and has held it in 25 quarters since. The position peaked at $79M in Q2 2024. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Loomis, Sayles & Company held 2,971 shares of Medpace worth $1.57M as of Q2 2026.
  • Loomis, Sayles & Company sold 54 Medpace shares in Q2 2026, an estimated $24.9K.
  • Medpace made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #499 holding.
  • Loomis, Sayles & Company first reported a position in Medpace in Q4 2016 and has held it in 25 quarters since.
  • Loomis, Sayles & Company's Medpace position peaked at $79M in Q2 2024.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.